Equity and Noncommunicable Disease Reduction under the Sustainable Development Goals

Harald Schmidt and Anne Barnhill highlight the need to ensure equity in the proposed Sustainable Development Goals.

Vyšlo v časopise: Equity and Noncommunicable Disease Reduction under the Sustainable Development Goals. PLoS Med 12(9): e32767. doi:10.1371/journal.pmed.1001872
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001872

Souhrn

Harald Schmidt and Anne Barnhill highlight the need to ensure equity in the proposed Sustainable Development Goals.

Zdroje

1. World Health Organization. World Health Statistics 2015—Part 2: Global health indicators. Geneva: WHO. 2015.

2. Waage J, Banerji R, Campbell O, Chirwa E, Collender G, Dieltiens V, et al. The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015. The Lancet. 2010 Sep;376(9745):991–1023.

3. Open Working Group Proposal for Sustainable Development Goals [Internet]. [cited 2014 Sep 18]. http://sustainabledevelopment.un.org/focussdgs.html.

4. United Nations General Assembly. Resolution adopted by the General Assembly [Internet]. 2011 [cited 2014 Sep 18] p. 1. http://cdrwww.who.int/entity/nmh/events/un_ncd_summit2011/political_declaration_en.pdf.

5. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. 2013 [cited 2014 Aug 31]; http://apps.who.int/iris/handle/10665/94384.

6. United Nations Secretary-General. Note by the Secretary-General transmitting the report of the Director-General of the World Health Organization on the progress achieved in realizing the commitments made in the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases (NCDs). WHO. 2013.

7. Watkins K. Leaving no one behind: an agenda for equity. The Lancet. 2014 Dec;384(9961):2248–2255.

8. Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. The Lancet. 2013;381(9866):585–97.

9. World Health Organization. Equity, social determinants and public health programmes. World Health Organization; 2010.

10. Verguet S, Gauvreau CL, Mishra S, MacLennan M, Murphy SM, Brouwer ED, et al. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Glob Health. 2015;3(4):206–16.

11. Johri M, Norheim OF. Can cost-effectiveness analysis integrate concerns for equity? Systematic review. Int J Technol Assess Health Care. 2012;28(2):125–32. doi: 10.1017/S0266462312000050 22494637

12. World Health Organization. Making Fair Choices on the Path to Universal Health Coverage: Final Report of the WHO Consultative Group on Equity and Universal Health Coverage. Gevena: World Health Organization; 2014.

13. Alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, et al. Embedding non-communicable diseases in the post-2015 development agenda. The Lancet. 2013;381(9866):566–74.

14. Hosseinpoor AR, Bergen N, Koller T, Prasad A, Schlotheuber A, Valentine N, et al. Equity-Oriented Monitoring in the Context of Universal Health Coverage. PLoS Med. 2014 Sep 22;11(9):e1001727. doi: 10.1371/journal.pmed.1001727 25243463

15. Schmidt H. Personal responsibility in the NHS Constitution and the social determinants of health approach: competitive or complementary? Health Econ Policy Law. 2009;4(2):129–38.

16. Link BG, Phelan JC. Stigma and its public health implications. The Lancet. 2006;367(9509):528–9.